30-Second Executive Brief
Executive Assessment
Humana functions as an established institution within Healthcare & Life Sciences, backed by 0% sourcing coverage, with accelerating strategic relevance.
- Maintains 2 mapped relationships across the graph
- 0% sourcing coverage across sourced relationships
- Tracked as established institution within the Healthcare & Life Sciences category
Executive Snapshot
- Strategic Role
- Established Institution
- Sourcing Coverage
- 0%
- Ecosystem Influence
- High
- Strategic Momentum
- Accelerating
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 2
- Technology Domains
- 3
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
Major US health insurance company with a leading Medicare Advantage business; reported Q2 2026 revenue of $40.9 billion (up 26.2% year-over-year) driven by membership growth and higher premiums, though the company lowered its GAAP EPS guidance for 2026 to 'at least $6.52' while affirming adjusted EPS guidance of 'at least $9.00' amid pharmacy cost trends and Star Ratings impacts.
Leading Indicators
Hiring and patent filing trends — the underlying numbers Momentum is computed from. Insider filing activity is tracked separately under Sources below.
Additional Intelligence Signals
Patent citation lineage, earnings-call mentions, and federal contract disclosures — automatically collected, not yet visible anywhere else on the site.
Federal contract disclosures
Department of Defense — $51,269,205,263: IGF::OT::IGF
USAspending.gov · Aug 1, 2016
Department of Defense — $9,257,087,985: TRICARE MANAGED CARE SUPPORT SERVICES CONTRACT, 5TH GENERATION EAST REGION
USAspending.gov · Feb 1, 2023
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
1 source
- TradingView — Humana Inc Q2 2026: Revenue $40.9B, EPS $5.73news
Latest Activity
- FilingHumana filed an 8-K (items 7.01)8-K
Insider Filing Activity
Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Sep 7, 2026
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding Humana — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Humana's Timeline
A sourced, dated history of Humana's key moments — founding to present.
Jul 2026 · Q2 2026 revenue rises 26.2% to $40.9 billion amid membership growth
Humana reported Q2 2026 revenue of $40.9 billion, up 26.2% year-over-year from $32.4 billion, with diluted EPS of $5.73, driven by membership growth and higher premiums; the company lowered its GAAP EPS guidance for 2026 to at least $6.52 while affirming adjusted EPS guidance of at least $9.00 amid pharmacy cost trends and Star Ratings impacts.